2025-26年季节性流感疫苗效果中期估计——加利福尼亚州,2025年10月至2026年1月
加利福尼亚州利用链接的流感疫苗接种与公共卫生监测数据,采用病例对照设计估计2025-26季中期流感疫苗效果(VE)。所有年龄组对任何流感的VE为33%,6月龄至17岁儿童为39%,≥65岁成人为22%;对甲型流感阳性VE为32%,对乙型流感阳性VE为47%。
要点
- 本季中期估计显示流感疫苗接种与实验室确诊流感风险降低相关。
- 儿童青少年VE(39%)高于≥65岁成人(22%)。
- 对乙型流感VE(47%)高于甲型流感(32%)。
核心结论
- 流感疫苗接种与儿童和成人实验室确诊流感风险降低相关。
- CDPH建议所有≥6月龄人群每年接种流感疫苗以降低流感及流感相关不良健康结局风险。
研究设计与样本
- 采用病例对照研究设计,比较病例患者与对照患者的季节性流感疫苗接种比值。
- 数据来源为链接的流感疫苗接种与加州公共卫生部(CDPH)公共卫生流感监测数据。
主要发现
- 病例患者中22%接种流感疫苗,对照患者中27%接种流感疫苗。
- 所有年龄组对任何流感的VE为33%。
- 6月龄至17岁儿童和青少年的VE为39%。
- ≥65岁成人的VE为22%。
- 对甲型流感阳性检测结果的VE为32%,对乙型流感阳性检测结果的VE为47%。
关键数值与推荐
- CDPH推荐所有≥6月龄人群每年接种流感疫苗。
临床怎么用
- 州级中期VE估计可为当地公共卫生部门及时采取流感预防和治疗行动提供参考。
- 临床与公共卫生实践中应继续推动≥6月龄人群每年接种流感疫苗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Interim estimates of state-level influenza vaccine effectiveness (VE) can help guide timely local public health actions for prevention and treatment of influenza. Linked influenza vaccination and public health influenza surveillance data from California allowed estimation of interim influenza VE by comparing the odds of seasonal influenza vaccination among persons who received positive and negative influenza test results reported to the California Department of Public Health (CDPH) using a case-control study design. During October 1, 2025-January 31, 2026, a total of 952,765 influenza laboratory test results were reported to CDPH. These data were analyzed, including results for 86,369 (9%) persons with receipt of a positive influenza test result (case-patients) and 866,396 (91%) with receipt of a negative test result (control patients). Overall, 22% of case-patients and 27% of control patients were vaccinated against influenza. Interim VE against any influenza was 33% for all age groups, 39% for children and adolescents aged 6 months-17 years, and 22% for adults aged ≥65 years; VE was 32% against a positive influenza A test result, and 47% against a positive influenza B test result. These results suggest that influenza vaccination was associated with reduced odds for laboratory-confirmed influenza among children and adults. CDPH recommends annual influenza vaccination for all persons aged ≥6 months to reduce the risk for influenza and influenza-associated adverse health outcomes.
引用
- Zhu S, Quint J, León TM, et al. Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - California, October 2025-January 2026. MMWR Morb Mortal Wkly Rep. 2026. PMID: 41818142. doi:10.15585/mmwr.mm7509a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。